Effects  	Effects  	 NNS	O
of  	of  	 IN	O
dioscorea  	dioscorea  	 JJ	B-NP
modified  	modified  	 JJ	I-NP
pill  	pill  	 NN	I-NP
on  	on  	 IN	O
cognitive  	cognitive  	 JJ	B-NP
impairment  	impairment  	 NN	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VCIND 	VCIND 	 NNP	B-NP
:  	:  	 :	O
an  	an  	 DT	O
preliminary  	preliminary  	 JJ	B-NP
study  	study  	 NN	I-NP
of  	of  	 IN	O
proton  	proton  	 JJ	O
magnetic  	magnetic  	 JJ	B-NP
resonance  	resonance  	 NN	I-NP
spectroscopy  	spectroscopy  	 NN	I-NP
To  	To  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
evaluation  	evaluation  	 NN	I-NP
of  	of  	 IN	O
proton  	proton  	 JJ	O
magnetic  	magnetic  	 JJ	O
resonance  	resonance  	 NN	O
spectroscopy  	spectroscopy  	 NNS	O
( 	( 	 -LRB-	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
) 	) 	 -RRB-	O
H-MRS 	H-MRS 	 NNP	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
vascular  	vascular  	 JJ	B-NP
cognitive  	cognitive  	 NNS	I-NP
impairment  	impairment  	 VBP	I-NP
no  	no  	 DT	I-NP
dementia  	dementia  	 NN	I-NP
( 	( 	 -LRB-	O
VCIND 	VCIND 	 NNP	B-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
dioscorea  	dioscorea  	 JJ	B-NP
modified  	modified  	 JJ	I-NP
pill 	pill 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
100  	100  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VCIND  	VCIND  	 NNP	B-NP
were  	were  	 VBD	O
randomly  	randomly  	 RB	O
assigned  	assigned  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
dioscorea  	dioscorea  	 JJ	B-NP
modified  	modified  	 JJ	I-NP
pill  	pill  	 NN	I-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
50 	50 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
aricept  	aricept  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
50 	50 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
And  	And  	 CC	O
50  	50  	 CD	O
healthy  	healthy  	 JJ	O
volunteers  	volunteers  	 NNS	O
were  	were  	 VBD	O
recruited  	recruited  	 VBN	O
as  	as  	 IN	O
normal  	normal  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
patient  	patient  	 NN	O
was  	was  	 VBD	O
examined  	examined  	 VBN	O
with  	with  	 IN	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
) 	) 	 -RRB-	O
H-MRS  	H-MRS  	 JJ	O
and  	and  	 CC	O
scored  	scored  	 VBD	O
with  	with  	 IN	O
mini-mental  	mini-mental  	 JJ	B-NP
state  	state  	 NN	I-NP
examination  	examination  	 NN	I-NP
( 	( 	 -LRB-	O
MMSE 	MMSE 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
dementia  	dementia  	 NN	I-NP
rating  	rating  	 NN	I-NP
( 	( 	 -LRB-	O
CDR 	CDR 	 NNP	B-NP
)  	)  	 -RRB-	O
scale  	scale  	 NN	B-NP
pre-  	pre-  	 NN	I-NP
and  	and  	 CC	O
post-treatment 	post-treatment 	 JJ	B-NP
.  	.  	 .	O
After  	After  	 IN	O
therapy 	therapy 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
NAA 	NAA 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Cr  	Cr  	 NNP	I-NP
ratios  	ratios  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
itemized  	itemized  	 JJ	O
scores  	scores  	 NNS	O
of  	of  	 IN	O
cognitive  	cognitive  	 JJ	B-NP
scale  	scale  	 NN	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
pre-therapy  	pre-therapy  	 NNP	B-NP
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
difference  	difference  	 NN	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
dioscorea  	dioscorea  	 JJ	B-NP
modified  	modified  	 JJ	I-NP
pill  	pill  	 NN	I-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
MMSE  	MMSE  	 NNP	B-NP
( 	( 	 -LRB-	O
26.5  	26.5  	 CD	O
±  	±  	 CD	O
2.0 	2.0 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
CDR 	CDR 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
0.14  	0.14  	 CD	I-NP
±  	±  	 CD	O
0.23 	0.23 	 CD	O
) 	) 	 -RRB-	B-NP
) 	) 	 -RRB-	I-NP
vs 	vs 	 NNS	I-NP
( 	( 	 -LRB-	I-NP
MMSE 	MMSE 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
25.1  	25.1  	 CD	I-NP
±  	±  	 CD	O
2.3 	2.3 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
CDR 	CDR 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
0.5 	0.5 	 CD	I-NP
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
But  	But  	 CC	O
no  	no  	 DT	O
difference  	difference  	 NN	O
existed  	existed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
aricept  	aricept  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
>  	>  	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
) 	) 	 -RRB-	O
H-MRS  	H-MRS  	 NNP	O
may  	may  	 MD	O
objectively  	objectively  	 RB	O
reflect  	reflect  	 VB	O
cognitive  	cognitive  	 JJ	B-NP
dysfunction  	dysfunction  	 NN	I-NP
in  	in  	 IN	O
VCIND  	VCIND  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
And  	And  	 CC	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
important  	important  	 JJ	O
values  	values  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
evaluation  	evaluation  	 NN	I-NP
of  	of  	 IN	I-NP
VCIND  	VCIND  	 NNP	I-NP
with  	with  	 IN	O
dioscorea  	dioscorea  	 JJ	B-NP
modified  	modified  	 JJ	I-NP
pill 	pill 	 NN	I-NP
.  	.  	 .	O
